Speakers

 

Conference Chair

Bob Go, Global Managing Director, Life Sciences and Health Care, Deloitte Touche Tohmatsu

Andrew Jack, Pharmaceuticals Correspondent, Financial Times

Keynote(s)

Kelly Martin, Chief Executive Officer, Elan Corporation

Arthur Higgins, Chairman, Board of Management, Bayer HealthCare AG

Dr Martin Mackay, President, Global Research & Development, Pfizer

Thomas Lönngren, Executive Director, European Medicines Agency (EMEA)

Lord Paul Drayson of Kensington, Minister of State for Science and Innovation, Department of Business Innovation and Skills, United Kingdom

Dr Swati Piramal, Vice Chairperson, Piramal Life Sciences Limited

Jonathan Peacock, Chief Financial & Administration Officer, Novartis Pharma AG

Speaker(s)

Alan Barge, Vice President and Head of Oncology TA, AstraZeneca

M. Jean-Luc Belingard, Chairman and CEO, Ipsen SA

Paul Cload, Executive, Cardiology Marketing, GE Healthcare

Simon Hammett, Head of Life Sciences & Healthcare UK, Deloitte

Patrick Hopkinson, Director of Portfolio Partnership Marketing, GlaxoSmithKline UK

Stephen Jones, Partner, Baker & McKenzie LLP

Fred Lindemans, Vice President and General Manager, Bakken Research Center, Medtronic

Robert Mansfield, CEO, Neuropharm

Michael Naimoli, National Director, US Life Sciences, Microsoft Corporation

Stafford O'Kelly, Vice President, Molecular Diagnostics and President, Abbott

Laurie Stelzer, Executive Director, Business Development, Amgen

Andrew Thompson, President and CEO, Proteus Biomedical

Umang Vohra, Chief Financial Officer, Dr. Reddy's Laboratories Limited

Chris Viehbacher, Chief Executive Officer, Sanofi-aventis

Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs, US Food and Drug Administration

François Maisonrouge, Senior Managing Director, Evercore Partners

Sigurdur Oli Olafsson, Chief Executive Officer, Actavis

Harpal S. Kumar, Chief Executive Officer, Cancer Research UK

Alex Howarth, Chief Business Officer, moksha8 Pharmaceuticals, Inc.

Ronald Ede, Chief Financial Officer, Mindray Medical International Limited

Dr Gbola Amusa, Managing Director, Global Pharmaceuticals Sector Coordinator, and Head of European Pharmaceuticals Research, UBS Limited

Professor Alan Fairlamb, Wellcome Principle Research Fellow and Professor of Biochemistry, College of Life Sciences University of Dundee

Anjali Nayyar, Country Programme Director, PATH, India

Mungo Park, Chairman, Innovator Capital Limited

Mark Keatley, Executive Vice President of Finance & IT, Actavis

Rolf Soderstrom, Chief Financial Officer, BTG plc

Prof Joyce Tait CBE, Scientific Adviser, ESRC Innogen Centre, University of Edinburgh

Julian Thompson, Vice President Global Regulatory Head Primary Care Business Unit, Pfizer Limited